Thirty-three consecutive liver-transplant recipients were prospectively studied over a 37-mo
period for evidence of cytomegalovirus infection. Sixteen (48%) episodes of cytomegalovirus
infection were identified; 9 were primary infections and 7 were recurrent infections.
Beginning with patient 8, γ-globulin prophylaxis was routinely administered to most patients.
Twelve potential risk factors for cytomegalovirus infection were evaluated and included
pretransplant cytomegalovirus serological status of donor and recipient; recipient's age, sex …